{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T23:03:25Z","timestamp":1791846205662,"version":"4.3.4"},"reference-count":64,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,12,7]],"date-time":"2020-12-07T00:00:00Z","timestamp":1607299200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Cardiology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/j.jacc.2020.11.056","type":"journal-article","created":{"date-parts":[[2021,2,2]],"date-time":"2021-02-02T13:13:24Z","timestamp":1612271604000},"page":"620-628","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":92,"title":["Red Yeast Rice for Hypercholesterolemia"],"prefix":"10.1016","volume":"77","author":[{"given":"Arrigo F.G.","family":"Cicero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Fogacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacc.2020.11.056_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40256-019-00358-0","article-title":"Spotlight from the American Society for Preventive Cardiology on Key Features of the 2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA Guidelines on the Management of Blood Cholesterol","volume":"20","author":"Wong","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"10.1016\/j.jacc.2020.11.056_bib2","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1161\/CIR.0000000000000757","article-title":"Heart disease and stroke statistics-2020 update: a report from the American Heart Association","volume":"141","author":"Virani","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.11.056_bib3","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.pathol.2018.10.013","article-title":"Diet, exercise and weight loss and dyslipidaemia","volume":"51","author":"Clifton","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/j.jacc.2020.11.056_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2018.05.015","article-title":"Nutraceuticals and functional foods for the control of plasma cholesterol levels. An intersociety position paper","volume":"134","author":"Poli","year":"2018","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacc.2020.11.056_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pcad.2018.05.004","article-title":"Portfolio dietary pattern and cardiovascular disease: a systematic review and meta-analysis of controlled trials","volume":"61","author":"Chiavaroli","year":"2018","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2020.11.056_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1093\/ajcn.83.3.582","article-title":"Assessment of the longer-term effects of a dietary portfolio of cholesterol-lowering foods in hypercholesterolemia","volume":"83","author":"Jenkins","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacc.2020.11.056_bib7","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jacc.2020.11.056_bib8","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s11883-011-0210-3","article-title":"Effects of eicosapentaenoic acid versus docosahexaenoic acid on serum lipids: a systematic review and meta-analysis","volume":"13","author":"Wei","year":"2011","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/j.jacc.2020.11.056_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1080\/07315724.2011.10719947","article-title":"Soy protein effects on serum lipoproteins: a quality assessment and meta-analysis of randomized, controlled studies","volume":"30","author":"Anderson","year":"2011","journal-title":"J\u00a0Am Coll Nutr"},{"key":"10.1016\/j.jacc.2020.11.056_bib10","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/j.nut.2016.04.007","article-title":"Lipid-modifying effects of nutraceuticals: an evidence-based approach","volume":"32","author":"Sahebkar","year":"2016","journal-title":"Nutrition"},{"key":"10.1016\/j.jacc.2020.11.056_bib11","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2020.11.056_bib12","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1093\/nutrit\/nux047","article-title":"Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel","volume":"75","author":"Cicero","year":"2017","journal-title":"Nutr Rev"},{"key":"10.1016\/j.jacc.2020.11.056_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1007\/s40264-018-0661-3","article-title":"Adverse events to food supplements containing red yeast rice: comparative analysis of FAERS and CAERS Reporting Systems","volume":"41","author":"Raschi","year":"2018","journal-title":"Drug Saf"},{"key":"10.1016\/j.jacc.2020.11.056_bib14","doi-asserted-by":"crossref","first-page":"192","DOI":"10.14797\/mdcj-15-3-192","article-title":"Red yeast rice for hypercholesterolemia","volume":"15","author":"Cicero","year":"2019","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.jacc.2020.11.056_bib15","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1016\/j.jpba.2004.04.004","article-title":"Identification and chemical profiling of monacolins in red yeast rice using high-performance liquid chromatography with photodiode array detector and mass spectrometry","volume":"35","author":"Li","year":"2004","journal-title":"J\u00a0Pharm Biomed Anal"},{"key":"10.1016\/j.jacc.2020.11.056_bib16","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1039\/C8FO02594K","article-title":"Re-examining the role of the gut microbiota in the conversion of the lipid-lowering statin monacolin K (lovastatin) into its active \u03b2-hydroxy acid metabolite","volume":"10","author":"Beltr\u00e1n","year":"2019","journal-title":"Food Funct"},{"key":"10.1016\/j.jacc.2020.11.056_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.atherosclerosis.2015.04.004","article-title":"Traditional Chinese lipid-lowering agent red yeast rice results in significant LDL reduction but safety is uncertain-a systematic review and meta-analysis","volume":"240","author":"Gerards","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2020.11.056_bib18","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.numecd.2009.10.015","article-title":"The treatment of hypercholesterolemic children: efficacy and safety of a combination of red yeast rice extract and policosanols","volume":"21","author":"Guardamagna","year":"2011","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jacc.2020.11.056_bib19","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.phymed.2015.10.011","article-title":"Combinations of phytomedicines with different lipid lowering activity for dyslipidemia management: the available clinical data","volume":"23","author":"Cicero","year":"2016","journal-title":"Phytomedicine"},{"key":"10.1016\/j.jacc.2020.11.056_bib20","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.phrs.2016.04.021","article-title":"The effects of a nutraceutical combination on plasma lipids and glucose: a systematic review and meta-analysis of randomized controlled trials","volume":"110","author":"Pirro","year":"2016","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacc.2020.11.056_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.amjcard.2018.09.041","article-title":"Usefulness of low-dose statin plus ezetimibe and\/or nutraceuticals in patients with coronary artery disease intolerant to high-dose statin treatment","volume":"123","author":"Marazzi","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.056_bib22","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12986-017-0214-2","article-title":"Effect of a short-term dietary supplementation with phytosterols, red yeast rice or both on lipid pattern in moderately hypercholesterolemic subjects: a three-arm, double-blind, randomized clinical trial","volume":"14","author":"Cicero","year":"2017","journal-title":"Nutr Metab"},{"key":"10.1016\/j.jacc.2020.11.056_bib23","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ahj.2013.03.019","article-title":"Phytosterols, red yeast rice, and lifestyle changes instead of statins: a randomized, double-blinded, placebo-controlled trial","volume":"166","author":"Becker","year":"2013","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacc.2020.11.056_bib24","first-page":"110","article-title":"Powdered red yeast rice and plant stanols and sterols to lower cholesterol","volume":"9","author":"Feuerstein","year":"2012","journal-title":"J\u00a0Diet Suppl"},{"key":"10.1016\/j.jacc.2020.11.056_bib25","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s40292-016-0163-2","article-title":"Effects of a combined nutraceutical on lipid pattern, glucose metabolism and inflammatory parameters in moderately hypercholesterolemic subjects: a double-blind, cross-over, randomized clinical trial","volume":"24","author":"Cicero","year":"2016","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.jacc.2020.11.056_bib26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.3109\/09637486.2013.809405","article-title":"A\u00a0combined natural supplement lowers LDL cholesterol in subjects with moderate untreated hypercholesterolemia: a randomized placebo-controlled trial","volume":"64","author":"Barrat","year":"2013","journal-title":"Int J Food Sci Nutr"},{"key":"10.1016\/j.jacc.2020.11.056_bib27","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1007\/s00394-012-0486-2","article-title":"Effect on LDL-cholesterol of a large dose of a dietary supplement with plant extracts in subjects with untreated moderate hypercholesterolaemia: a randomised, double-blind, placebo-controlled study","volume":"52","author":"Barrat","year":"2013","journal-title":"Eur J Nutr"},{"key":"10.1016\/j.jacc.2020.11.056_bib28","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1161\/01.CIR.0000139985.81163.CE","article-title":"Xuezhikang, an extract of cholestin, protects endothelial function through antiinflammatory and lipid-lowering mechanisms in patients with coronary heart disease","volume":"110","author":"Zhao","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.jacc.2020.11.056_bib29","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1007\/s12325-017-0580-1","article-title":"Short-term effects of a combined nutraceutical on lipid level, fatty liver biomarkers, hemodynamic parameters, and estimated cardiovascular disease risk: a double-blind, placebo-controlled randomized clinical trial","volume":"34","author":"Cicero","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/j.jacc.2020.11.056_bib30","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000445359","article-title":"Middle-term dietary supplementation with red yeast rice plus coenzyme Q10 improves lipid pattern, endothelial reactivity and arterial stiffness in moderately hypercholesterolemic subjects","volume":"68","author":"Cicero","year":"2016","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.jacc.2020.11.056_bib31","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.atherosclerosis.2018.11.026","article-title":"NUtraceutical TReatment for hYpercholesterolemia in HIV-infected patients: The NU-TRY(HIV) randomized cross-over trial","volume":"280","author":"Pirro","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2020.11.056_bib32","article-title":"Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis","volume":"4","author":"Matsuzawa","year":"2015","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.jacc.2020.11.056_bib33","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1161\/HYPERTENSIONAHA.112.194779","article-title":"Prediction of cardiovascular events and all-cause mortality with brachial-ankle elasticity index: a systematic review and meta-analysis","volume":"60","author":"Vlachopoulos","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/j.jacc.2020.11.056_bib34","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/j.amjcard.2008.02.056","article-title":"Chinese Coronary Secondary Prevention Study Group. Effect of Xuezhikang, an extract from red yeast Chinese rice, on coronary events in a Chinese population with previous myocardial infarction","volume":"101","author":"Lu","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.056_bib35","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1177\/0091270009337509","article-title":"Beneficial impact of Xuezhikang on cardiovascular events and mortality in elderly hypertensive patients with previous myocardial infarction from the China Coronary Secondary Prevention Study (CCSPS)","volume":"49","author":"Li","year":"2009","journal-title":"J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.jacc.2020.11.056_bib36","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators","volume":"335","author":"Sacks","year":"1996","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.11.056_bib37","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jacc.2020.11.056_bib38","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/j.jacc.2020.11.056_bib39","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2261-15-6","article-title":"The difference between Asian and Western in the effect of LDL-C lowering therapy on coronary atherosclerotic plaque: a meta-analysis report","volume":"15","author":"Li","year":"2015","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.jacc.2020.11.056_bib40","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1093\/qjmed\/hcy278","article-title":"Effects of red yeast rice prescription (LipoCol Forte) on adverse outcomes of surgery","volume":"112","author":"Chen","year":"2019","journal-title":"QJM"},{"key":"10.1016\/j.jacc.2020.11.056_bib41","first-page":"5368","article-title":"Scientific opinion on the safety of monacolins in red yeast rice. EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS). European Food Safety Authority (EFSA), Parma, Italy","volume":"16","year":"2018","journal-title":"EFSA Journal"},{"key":"10.1016\/j.jacc.2020.11.056_bib42","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1023360313459","article-title":"Characterization of a non-pigment producing Monascus purpureus mutant strain","volume":"83","author":"Rasheva","year":"2003","journal-title":"Antonie Van Leeuwenhoek"},{"key":"10.1016\/j.jacc.2020.11.056_bib43","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/0304-3835(83)90165-9","article-title":"Tumorigenicity of citrinin in male F344 rats","volume":"17","author":"Arai","year":"1983","journal-title":"Cancer Lett"},{"key":"10.1016\/j.jacc.2020.11.056_bib44","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/jat.1354","article-title":"Experimentally induced citrinin and endosulfan toxicity in pregnant Wistar rats: histopathological alterations in liver and kidneys of fetuses","volume":"28","author":"Singh","year":"2008","journal-title":"J\u00a0Appl Toxicol"},{"key":"10.1016\/j.jacc.2020.11.056_bib45","first-page":"2605","article-title":"Scientific Opinion on the risks for public and animal health related to the presence of citrinin in food and feed. EFSA Panel on Contaminants in the Food Chain (CONTAM). European Food Safety Authority (EFSA), Parma, Italy","volume":"10","year":"2012","journal-title":"EFSA Journal"},{"key":"10.1016\/j.jacc.2020.11.056_bib46","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/archinternmed.2010.382","article-title":"Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!","volume":"170","author":"Gordon","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.jacc.2020.11.056_bib47","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/0003-9861(91)90551-S","article-title":"Biotransformation of lovastatin. IV. Identification of cytochrome P450 3A proteins as the major enzymes responsible for the oxidative metabolism of lovastatin in rat and human liver microsomes","volume":"290","author":"Wang","year":"1991","journal-title":"Arch Biochem Biophys"},{"key":"10.1016\/j.jacc.2020.11.056_bib48","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0009-9236(98)90034-0","article-title":"Grapefruit juice greatly increases serum concentrations of lovastatin and lovastatin acid","volume":"63","author":"Kantola","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jacc.2020.11.056_bib49","series-title":"Toxicological evaluation of red mould rice: an update","year":"2012"},{"key":"10.1016\/j.jacc.2020.11.056_bib50","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/00007890-200210270-00028","article-title":"Rhabdomyolysis due to red yeast rice (Monascus purpureus) in a renal transplant recipient","volume":"74","author":"Prasad","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.jacc.2020.11.056_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.phrs.2019.02.028","article-title":"Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group; International Lipid Expert Panel (ILEP). Safety of red yeast rice supplementation: a systematic review and meta-analysis of randomized controlled trials","volume":"143","author":"Fogacci","year":"2019","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.jacc.2020.11.056_bib52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jacc.2018.04.040","article-title":"International Lipid Expert Panel (ILEP). The role of nutraceuticals in statin intolerant patients","volume":"72","author":"Banach","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.056_bib53","first-page":"743473","article-title":"Mediterranean diet and red yeast rice supplementation for the management of hyperlipidemia in statin-intolerant patients with or without type 2 diabetes","volume":"2013","author":"Sartore","year":"2013","journal-title":"Evid Based Complement Alternat Med"},{"key":"10.1016\/j.jacc.2020.11.056_bib54","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1016\/j.amjcard.2010.01.337","article-title":"Red yeast rice and statin-intolerant patients","volume":"105","author":"Cicero","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.056_bib55","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.amjcard.2009.08.672","article-title":"Tolerability of red yeast rice (2,400\u00a0mg twice daily) versus pravastatin (20\u00a0mg twice daily) in patients with previous statin intolerance","volume":"105","author":"Halbert","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.056_bib56","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.1016\/j.amjcard.2015.09.023","article-title":"Usefulness of nutraceuticals (Armolipid Plus) versus ezetimibe and combination in statin-intolerant patients with dyslipidemia with coronary heart disease","volume":"116","author":"Marazzi","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacc.2020.11.056_bib57","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1080\/03007995.2016.1190326","article-title":"Additional therapy for cholesterol lowering in ezetimibe-treated, statin-intolerant patients in clinical practice: results from an internal audit of a university lipid clinic","volume":"32","author":"Cicero","year":"2016","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/j.jacc.2020.11.056_bib58","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.amjmed.2017.05.013","article-title":"Red yeast rice preparations: are they suitable substitutions for statins?","volume":"130","author":"Dujovne","year":"2017","journal-title":"Am J Med"},{"issue":"7","key":"10.1016\/j.jacc.2020.11.056_bib59","first-page":"2304","volume":"9","year":"2011","journal-title":"EFSA Journal"},{"key":"10.1016\/j.jacc.2020.11.056_bib60","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jacc.2020.11.056_bib61","article-title":"The burden of cholesterol accumulation through the lifespan: why pharmacological intervention should start earlier to go further?","author":"Zambon","year":"2020","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/j.jacc.2020.11.056_bib62","doi-asserted-by":"crossref","first-page":"2979","DOI":"10.1016\/j.jacc.2017.10.024","article-title":"Normal LDL-cholesterol levels are associated with subclinical atherosclerosis in the absence of risk factors","volume":"70","author":"Fern\u00e1ndez-Friera","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.jacc.2020.11.056_bib63","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.atherosclerosis.2014.04.016","article-title":"Factors associated with 2-year persistence in fully non reimbursed lipid-lowering treatments","volume":"235","author":"Cicero","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.jacc.2020.11.056_bib64","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1001\/archinternmed.2010.382","article-title":"Marked variability of monacolin levels in commercial red yeast rice products: buyer beware!","volume":"170","author":"Gordon","year":"2010","journal-title":"Arch Intern Med"}],"container-title":["Journal of the American College of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720379997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0735109720379997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T13:38:07Z","timestamp":1760017087000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0735109720379997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2]]},"references-count":64,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S0735109720379997"],"URL":"https:\/\/doi.org\/10.1016\/j.jacc.2020.11.056","relation":{},"ISSN":["0735-1097"],"issn-type":[{"value":"0735-1097","type":"print"}],"subject":[],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Red Yeast Rice for Hypercholesterolemia","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.11.056","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.09.619","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.09.617","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.12.009","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.jacc.2020.11.060","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}